Reuters logo
5 months ago
BRIEF-Cumberland Pharmaceuticals says caldolor demonstrates significant post surgical pain reduction and decrease in opioid use
March 27, 2017 / 8:56 PM / 5 months ago

BRIEF-Cumberland Pharmaceuticals says caldolor demonstrates significant post surgical pain reduction and decrease in opioid use

March 28 (Reuters) - Cumberland Pharmaceuticals Inc

* Cumberland Pharmaceuticals Inc says Caldolor demonstrates significant post surgical pain reduction and decrease in opioid use Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below